Search Results
Site Search
Classical Hematology 2023 - Insights
This Mayo Clinic conference will address the approach to the evaluation of frequently encountered blood count abnormalities. It will also provide an update on the diagnosis and management of common and rare nonmalignant blood disorders....
Classical Hematology 2023 - Insights
This Mayo Clinic conference will address the approach to the evaluation of frequently encountered blood count abnormalities. It will also provide an update on the diagnosis and management of common and rare nonmalignant blood disorders....
Classical Hematology 2023 - Insights
This Mayo Clinic conference will address the approach to the evaluation of frequently encountered blood count abnormalities. It will also provide an update on the diagnosis and management of common and rare nonmalignant blood disorders....
Classical Hematology 2023 - Insights
This Mayo Clinic conference will address the approach to the evaluation of frequently encountered blood count abnormalities. It will also provide an update on the diagnosis and management of common and rare nonmalignant blood disorders....
Classical Hematology 2023 - Insights
This Mayo Clinic conference will address the approach to the evaluation of frequently encountered blood count abnormalities. It will also provide an update on the diagnosis and management of common and rare nonmalignant blood disorders....
Classical Hematology 2023 - Insights
This Mayo Clinic conference will address the approach to the evaluation of frequently encountered blood count abnormalities. It will also provide an update on the diagnosis and management of common and rare nonmalignant blood disorders....
Classical Hematology 2023 - Insights
This Mayo Clinic conference will address the approach to the evaluation of frequently encountered blood count abnormalities. It will also provide an update on the diagnosis and management of common and rare nonmalignant blood disorders....
Classical Hematology 2023 - Insights
This Mayo Clinic conference will address the approach to the evaluation of frequently encountered blood count abnormalities. It will also provide an update on the diagnosis and management of common and rare nonmalignant blood disorders....
Mayo Clinic Laboratory and pathology research roundup: January 25 - Insights
Today's Topic Features: Measurable residual disease does not preclude prolonged progression-free survival in CLL treated with ibrutinib.
MCL Genetics Whole Genome Sequencing Flyer MC2775658
MCL Genetics Genome Sequencing Flyer GENOME SEQUENCING COMPREHENSIVE GENETIC TESTING ADVANCE DIAGNOSIS Clinic Laboratories genome sequencing WGS test utilizes generation
Addiction rehabilitation monitoring - Insights
Encompassing comprehensive profiles, confirmatory testing, and interpretive results reporting, addiction rehabilitation monitoring at Mayo Clinic Laboratories supports patients affected by substance use disorder in their rehabilitation and...
PIK3CA assay guides treatment of progressing breast cancer - Insights
Katherine Geiersbach, M.D., explains how Mayo Clinic Laboratories' PIK3CA assay informs breast cancer treatment. The assay identifies patients eligible for a certain second-line therapy when initial treatment has failed.
Pathways Case Studies: January 2023 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for January include the following sub-specialties: Bone and Soft Tissue Pathology,...
18th Bleeding and Thrombosing Diseases - Insights
This conference will provide reviews and updates about the laboratory and clinical aspects of bleeding and thrombosing disorders. Informational presentations will be supplemented with panel discussions and case presentations, followed by...
18th Bleeding and Thrombosing Diseases - Insights
This conference will provide reviews and updates about the laboratory and clinical aspects of bleeding and thrombosing disorders. Informational presentations will be supplemented with panel discussions and case presentations, followed by...
18th Bleeding and Thrombosing Diseases - Insights
This conference will provide reviews and updates about the laboratory and clinical aspects of bleeding and thrombosing disorders. Informational presentations will be supplemented with panel discussions and case presentations, followed by...
18th Bleeding and Thrombosing Diseases - Insights
This conference will provide reviews and updates about the laboratory and clinical aspects of bleeding and thrombosing disorders. Informational presentations will be supplemented with panel discussions and case presentations, followed by...
18th Bleeding and Thrombosing Diseases - Insights
This conference will provide reviews and updates about the laboratory and clinical aspects of bleeding and thrombosing disorders. Informational presentations will be supplemented with panel discussions and case presentations, followed by...
18th Bleeding and Thrombosing Diseases - Insights
This conference will provide reviews and updates about the laboratory and clinical aspects of bleeding and thrombosing disorders. Informational presentations will be supplemented with panel discussions and case presentations, followed by...
18th Bleeding and Thrombosing Diseases - Insights
This conference will provide reviews and updates about the laboratory and clinical aspects of bleeding and thrombosing disorders. Informational presentations will be supplemented with panel discussions and case presentations, followed by...
18th Bleeding and Thrombosing Diseases - Insights
This conference will provide reviews and updates about the laboratory and clinical aspects of bleeding and thrombosing disorders. Informational presentations will be supplemented with panel discussions and case presentations, followed by...
18th Bleeding and Thrombosing Diseases - Insights
This conference will provide reviews and updates about the laboratory and clinical aspects of bleeding and thrombosing disorders. Informational presentations will be supplemented with panel discussions and case presentations, followed by...
CPT codes and LOINC update: October 2023 - Insights
This page includes updates posted to Mayo Clinic Labs during the month of October.
In this month’s “Hot Topic,” Paul Jannetto, Ph.D., discusses the use of qualitative urine screening assays and quantitative confirmatory testing to determine compliance in pain management patients.
Mayo Clinic Laboratories’ genetic counselors are experts on heritable illness who provide a wealth of knowledge to guide appropriate testing utilization and interpret results.
Anatomic Pathology
Clinical Case Studies - Insights
The Pathways program provides anatomic and clinical pathology cases that include a history, potential answers, rationale, and relevant references directly from Mayo Clinic fellows, physicians, scientists, and allied health staff.
Clinical Pathology
CPT Codes and LOINC Update: April 2020 - Insights
View a full list of new CPT codes, Test Classification Updates, LOINC Codes, and Z-Codes posted to mayocliniclabs.com during the month of April.
International System of Units (SI) Conversion - Mayo Clinic Laboratories
Convert conventional units of measure to SI units.
Mayo Clinic Laboratory and pathology research roundup: May 30 - Insights
This week's research roundup feature: Clinical and molecular correlates of somatic and germline DDX41 variants in patients and families with myeloid neoplasms.
Reflecting on the MLS Program - Insights
Montana Smith, a student in Mayo Clinic’s Medical Laboratory Science program, reflects on her experience in the program.
The prostate health index or phi test reduces the need for prostate cancer biopsies by 30 percent.
Collaboration Paves the Way for Rapid Discovery in Autoimmune Neurology - Insights
Using advanced technology, scientists at Chan Zuckerberg (CZ) Biohub, Mayo Clinic and University of California, San Francisco (UCSF), have discovered an autoimmune disease that appears to affect men with testicular cancer.
Pathways Case Studies - Insights
The Pathways program provides anatomic and clinical pathology cases that include a history, potential answers, rationale, and relevant references directly from Mayo Clinic fellows, physicians, scientists, and allied health staff.
Whole genome sequencing - Insights
Check out Mayo Clinic Laboratories’ whole genome testing, a next-generation sequencing assay that interrogates nearly every base pair of an individual’s DNA, including the mitochondrial genome.
Dementia with Lewy bodies, Parkinson's, and multiple system atrophy - Insights
Learn more about how Mayo Clinic Laboratories' cerebrospinal fluid biomarker test for synucleinopathies, such as Parkinson’s disease and dementia with Lewy bodies, can accurately identify α-syn pathology even before definitive symptoms...
MGMR - Overview: Myasthenia Gravis Evaluation with Muscle-Specific Kinase (MuSK) Reflex, Serum
Diagnosing autoimmune myasthenia gravis (MG) in adults and children Distinguishing autoimmune from congenital MG in adults and children or other acquired forms of neuromuscular junction transmission disorders Establishing a quantitative...
AHUSD - Overview: Atypical Hemolytic Uremic Syndrome Complement Panel, Serum and Plasma
Detecting deficiencies in the alternative pathway that can cause atypical-hemolytic uremic syndrome, dense deposit disease, and C3 glomerulonephritis A second-tier test that aids in the differential diagnosis of thrombotic...
Week in Review: May 27 - Insights
Today's highlights include: Long COVID affects more older adults, US has a new dominant COVID-19 strain, and Gianrico Farrugia explains how we can transform healthcare by moving from pipeline to platform.
Metagenomic Sequencing - A Tool for Diagnosis of Central Nervous System Infection - Insights
PACE/State of FL - Metagenomic sequencing for diagnosing central nervous system infection. Content will be shared regarding technical details, clinical applications, and results interpretation, drawing on both current literature and...
PD-L1 Testing by Immunohistochemistry - Insights
In this month's "Hot Topic," Anja Roden, M.D., discusses the role of PD-L1 interaction in the immune system, challenges of PD-L1 testing, and current PD-L1 companion testing in various tumor types.
MCL - Hematopathology/Cytogenetics Test Request Form T726 - MC0767-05A
MCL - Hematopathology/Cytogenetics Test Request Form T726
Sickle cell disease: How new technologies are transforming patient lives - Insights
PACE/State of FL - The current knowledge regarding sickle cell disease from its genetic cause to the myriads of effects it can have for affected individuals.
Mayo Clinic Laboratory and pathology research roundup: November 1 - Insights
This week's research roundup features: Alliance A071401: phase II trial of focal adhesion kinase inhibition in meningiomas with somatic NF2 mutations
Mayo Clinic Laboratory and pathology research roundup: February 15 - Insights
This week's Research Roundup features: Activity of a hypochlorous acid-producing electrochemical bandage as assessed with a porcine explant biofilm model.
FDA-approved test expands options for Alzheimer's disease - Insights
Joshua Bornhorst, Ph.D., describes the new, FDA-approved Alzheimer's disease (AD) test and how it differs from Mayo Clinic Laboratories' existing AD evaluation. The laboratory will offer both tests, to ensure flexibility and options for...
Microsoft Word - mayo 2 out of state testing approval license updated.docx
Out of State Laboratory Testing Date: September 6, 2024 RE: Out of State Testing Approval HFD-OS41 MAYO CLINIC LABS-ROCHESTER SUPERIOR DRIVE is approved to perform Out of State Testing, located at 3050 SUPERIOR DRIVE NW,...
Vector-borne disease testing at Mayo Clinic Laboratories uses an algorithmic approach to ensure the right test for the right patient in the right geographic region. Our full-spectrum test menu includes assays for the most prevalent tick-...
We offer next-generation sequencing and comprehensive fluorescence in situ hybridization (FISH) panels, as well as extensive immunohistochemistry (IHC) offerings, to diagnose and monitor T-cell lymphoma.